Cytotoxicity of the new antimetabolite-bisphosphonate (5-FdU-alendronate) in comparison to standard therapeutics on breast and ovarian cancer cell lines in the ATP tumor chemosensitivity assay
Sarah Schott, Markus Wallwiener, Beate Kootz, Harald Seeger, Tanja Fehm, Hans NeubauerVolume:
30
Language:
english
Pages:
6
DOI:
10.1007/s10637-011-9688-3
Date:
August, 2012
File:
PDF, 673 KB
english, 2012